NASDAQ · Biotechnology

AnPac Bio-Medical Science Co., Ltd. (ANPC) Stock

$4.30 -3.15% NASDAQ: ANPC Healthcare

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types.

Valuation

MetricValue
Price$4.30
Market Cap$26.97M
P/E Ratio-0.54
P/B Ratio-4.07
P/S Ratio15.16
EPS (TTM)$-54.18
52-Week High$11.99
52-Week Low$2.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE742.86%
ROA-255.99%
ROCE4200.00%
Gross Margin69.21%
Operating Margin-698.59%
Net Margin-860.16%
Debt/Equity-0.90
Current Ratio0.32

Annual Financials (USD)

Metric20182019202020212022
Revenue$10.0M$11.0M$21.0M$18.0M$12.0M
Operating Profit$-44.0M$-89.0M$-93.0M$-106.0M$-84.0M
Net Profit$-42.0M$-102.0M$-81.0M$-120.0M$-104.0M
EPS$-3.76$-205.96$-143.99$-176.53$-54.18
Op Margin-425.4%-821.4%-454.1%-589.6%-698.6%

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$53.0M$53.0M$50.0M$67.0M$40.0M
Total Liabilities$75.0M$69.0M$47.0M$66.0M$50.0M
Cash$13.0M$6.0M$3.0M$9.0M$2.0M
Borrowings$26.0M$39.0M$8.0M$34.0M$12.0M

Latest News

London BTC Company, CelLBxHealth, Anglo Asian Mining, Galliford Try, NextEnergy Solar Fund Proactive · Jul 15, 2026 ACG Metals, Rockfire Resources, Sunda Energy, CelLBxHealth, Poolbeg Pharmaceutical Proactive · Jul 14, 2026 Solvonis Therapeutics, Tertiary Minerals, CelLBxHealth, Coinsilium, Eco Buildings, Frontier IP Proactive · Jun 26, 2026 CelLBxHealth PLC (ANPCF) Full Year 2025 Earnings Call Highlights: Strategic Partnerships and ... GuruFocus.com · Jun 24, 2026 Eco Buildings, Solvonis Therapeutics, CelLBxHealth, NextEnergy Solar Fund, Empire Metals, Coinsilium Proactive · Jun 22, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-31.0M$-49.0M$-59.0M$-72.0M$-55.0M
Investing Cash Flow$-6.0M$-7.0M$-5.0M$-8.0M$-3.0M
Financing Cash Flow$36.0M$46.0M$35.0M$83.0M$38.0M
Net Cash Flow$1.0M$-7.0M$-3.0M$6.0M$-7.0M
Free Cash Flow$-34.0M$-52.0M$-61.0M$-76.0M$-57.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-1.94
FCF Yield-31.04%
Quick Ratio0.32
Interest Coverage-225.57
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLKAllakos Inc. $0.33 +0.22% -0.25 $29.74M 0.00%
ANGNAngion Biomedica Corp. $1.00 +0.00% -0.42 $30.11M 0.00%
ELEVElevation Oncology, Inc. $0.37 -2.12% -0.47 $21.63M 0.00%
FRLNFreeline Therapeutics Holdings plc $6.49 +0.15% -0.29 $28.28M 0.00%
GMTXGemini Therapeutics, Inc. $1.35 +0.00% -0.22 $25.49M 0.00%

About AnPac Bio-Medical Science Co., Ltd.

AnPac Bio-Medical Science Co., Ltd. is a biotechnology firm that specializes in developing and commercializing tests designed for the early detection and screening of various cancer types. These diagnostic tools leverage the company's unique Cancer Differentiation Analysis (CDA) technology and associated devices. AnPac Bio primarily provides these solutions to corporate entities and life insurance companies across the People's Republic of China. Additionally, the company extends its offerings to include comprehensive physical examination package services. AnPac Bio was established in 2010 and maintains its main operational base in Lishui, China.

AnPac Bio-Medical Science Co., Ltd. is headquartered in CN.

AnPac Bio-Medical Science Co., Ltd. (ANPC) stock trades at $4.30 with a market capitalization of $26.97M. The stock is valued at a price-to-earnings (P/E) ratio of -0.54, price-to-book of -4.07, price-to-sales of 15.16. Over the past 52 weeks the stock has ranged between $2.60 and $11.99, and currently trades 64.1% below its 52-week high.

On profitability, AnPac Bio-Medical Science Co., Ltd. generates a return on equity (ROE) of 742.86% — well above the market average, a sign of a high-quality business, return on capital employed of 4200.00%, an operating margin of -698.59%, a net profit margin of -860.16%.

Official website: www.anpacbio.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides